Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 701–800 of 999
Microbe-driven immune suppression in colorectal cancer: the Fusobacterium nucleatum playbook
Wuyi, W., & Tao, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795703 · Cited by 15
MacFarland, S. P., Maese, L. D., Rednam, S. P., Kamihara, J., Perrino, M. R., Nichols, K. E., Brodeur, G. M., Schiffman, J. D., Plon, S. E., Diller, L., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0215 · Cited by 9
Genetic heterogeneity of colorectal cancer and the microbiome
Senchukova, M. A. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i3.443 · Cited by 9
Sun, R., Chen, H., Yao, S., Yu, Z., Chen, L., & Huang, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1178714 · Cited by 11
“Alterations in microbial composition modulated local responses and produced toxin genes, thus playing a regulatory role in tumor development (Dejea et al., 2018; Garrett, 2019; Janney et al., 2020).”
BackgroundRifkin, S. B., Sze, M. A., Tuck, K., Koeppe, E. S., Stoffel, E. M., & Schloss, P. D. (2023) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-023-00925-4 · Cited by 13
Zhou, Q., Zhou, L., Chen, X., Chen, Q., & Hao, L. (2024) · Cancer Reports · doi:10.1002/cnr2.70063 · Cited by 13
Research Development, Optimization and Modifications of Anti-cancer Peptides
Sun, Z., Zhao, L., Yeh, S., Li, Z., & Ming, X. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200729163146 · Cited by 8
Microbiome and gastrointestinal malignancies
Sayed, I. M., Ramadan, H. K., El‐Mokhtar, M. A., & Abdel-Wahid, L. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.06.005 · Cited by 10
The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies
Tourelle, K. M., Boutin, S., Weigand, M. A., & Schmitt, F. C. F. (2021) · Biomedicines · doi:10.3390/biomedicines9101305 · Cited by 11
“For example, Escherichia coli and Bacteroides fragilis were associated with earlier tumour onset and increased morbidity in mouse models [15].”
BackgroundPhotoactivated Colibactin Probes Induce Cellular DNA Damage
Moodie, L. W. K., Hubert, M., Zhou, X. M., Albers, M. F., Lundmark, R., Wanrooij, S., & Hedberg, C. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201812326 · Cited by 9
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Aderonke, A. B., Ibrahim, R. B., & Huang, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184624 · Cited by 9
“The pro-tumorigenic role of gut dysbiosis has been described in different cancers through multiple mechanisms, including metabolic changes, inflammatory cytokines, oncogenic pathways, and adhesion molecules [28].”
BackgroundMicrobiome and Colorectal Cancer
Ahmed, I., & Umar, S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0416-7 · Cited by 12
Colibactin leads to a bacteria-specific mutation pattern and self-inflicted DNA damage
Lowry, E., Wang, Y., Dagan, T., & Mitchell, A. (2024) · Genome Research · doi:10.1101/gr.279517.124 · Cited by 8
“Colibactin-producing bacteria are not uncommon in the gut microbiome of healthy humans, yet their increased prevalence is evident in multiple human diseases ranging from inflammatory bowel disease to colon cancers (Buc et al. 2013; Eklöf et al. 2017; Dejea et al. 2018; Iyadorai et al. 2020).”
BackgroundResearch progress on the correlation between intestinal flora and colorectal cancer
Wang, X., Zhang, Q., Xu, R., Li, X., & Hong, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1416806 · Cited by 7
Xu, X., Xiong, S., Du, T., Li, J., Zhao, M., Zhao, M., Huang, T., Ren, H., Xiong, T., & Xie, M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105569 · Cited by 9
Expression of Fluorescence Reporters and Natural Products in Native Gut Escherichia coli
Liu, D., Ton, P., Zong, D. M., Zarrinpar, A., & Ding, Y. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00835 · Cited by 7
Microbiome and biofilm insights from normal vs tumor tissues in Thai colorectal cancer patients
Yincharoen, P., Mordmuang, A., Techarang, T., Tangngamsakul, P., Kaewubon, P., Atipairin, P., Janwanitchasthaporn, S., Goodla, L., & Karnjana, K. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00873-1 · Cited by 10
Bacteria and Carcinogenesis and the Management of Cancer: A Narrative Review
Plewa, P., Kiełbowski, K., Mentel, O., Figiel, K., Bakinowska, E., Becht, R., Banach, B., & Pawlik, A. (2025) · Pathogens · doi:10.3390/pathogens14050509 · Cited by 9
“It is also known that the TME itself is a habitat for bacteria, indicating a lack of tumor sterility [23,24].”
Liu, L., Shi, J., Wang, H., Du, H., Yang, J., Wei, K., Zhou, Z., Li, M., Huang, S., Zhan, L., et al. (2025) · mSystems · doi:10.1128/msystems.00198-25 · Cited by 7
“It is important to acknowledge that microorganisms primarily exert their effects by stimulating the mucosal tissue (49).”
Self-citationRole and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn’s disease
Xu, Y., Xie, R., Weng, Y., Fang, Y., Tao, S., Zhang, H., Chen, H., Han, A., Jiang, Q., & Liang, W. (2025) · International Journal of Colorectal Disease · doi:10.1007/s00384-025-04917-7 · Cited by 14
“Some strains of B. fragilis , particularly enterotoxigenic Bacteroides fragilis (ETBF), could increase mucosal permeability [64–66].”
Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations
Ramadan, Y. N., Alatawi, M. N., Albalawi, A. S., & Hetta, H. F. (2026) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00722-7 · Cited by 13
“…adenomatous polyposis patients to that of healthy individuals, genes encoding secreted oncotoxins, BFT, and colibactin (clbB), were shown to be significantly enriched [41] Ulcerative colitis (UC) and Crohn’s disease (CD) are two significant conditions that raise the risk of colorectal cancer.”
The bidirectional effects and mechanisms of the oral and gut microbiomes: a narrative review
Huo, T., Huang, X., Liao, J., Zhang, H., Hu, L., & Xie, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1697413 · Cited by 11
Intratumoral microbiome and gastrointestinal cancers
Li, S., Li, Q., & Lu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1047015 · Cited by 11
“fragilis can lead to colitis that triggers IL-17 production and inflammatory pathway activation, such as NF-kB, to facilitate tumor growth (54, 89).”
BackgroundOverview of microbial therapeutics in immunological disorders
Mishra, R., Mohanty, S., Mahapatra, S., & Prasad, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00008-2 · Cited by 8
Chen, K., McCulloch, J. A., Neves, R. D., Rodrigues, G. O. L., Hsieh, W., Gong, W., Yoshimura, T., Huang, J., Ó’hUigín, C., Difilippantonio, S., et al. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00557-w · Cited by 8
“S4A), rod-shaped morphology and positive staining with the E. coli probe EC1531 [33] (See figure on next page.)”
BackgroundSadeghi, M., Mestivier, D., Carbonnelle, É., Benamouzig, R., Khazaie, K., & Sobhani, I. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1313735 · Cited by 9
Salesse, L., Duval, A., Sauvanet, P., Silva, A. D., Barnich, N., Godfraind, C., Dalmasso, G., & Nguyen, H. T. T. (2024) · Autophagy · doi:10.1080/15548627.2024.2359770 · Cited by 8
Relevance of harmful intratumoral microbiota in cancer progression and its clinical application
Yu, R., Wang, S., & Han, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117238 · Cited by 9
Impact of gut microbiota and its metabolites on immunometabolism in colorectal cancer
Flory, M., Bravo, P., & Alam, A. M. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000050 · Cited by 11
Genomic alterations in Bacteroides fragilis favor adaptation in colorectal cancer microenvironment
Yang, H., Gan, Y., Jiang, S., Zhu, X., Xia, Y., Gong, D., Xie, X., Gong, Y., Zhang, Y., Lei, Q., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-11421-3 · Cited by 11
“Furthermore, recent studies have shown that the B. fragilis correlation with the development of CRC [18, 44].”
Bacterial biofilms and toxins prompt a perfect storm for colon cancer
Dickson, I. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.16 · Cited by 7
The biofilm characteristics and management of skin flap infection following cochlear implantation
Chen, X., Chen, Y., Zhang, R., Ye, S., Lin, Z., Nian, S., & Lin, C. S. (2022) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-n1985 · Cited by 7
Targeted depletion of pks + bacteria from a fecal microbiota using specific antibodies
Blanco‐Míguez, A., Marcos-Fernández, R., Guadamuro, L., Fdez‐Riverola, F., Cubiella, J., Lourenço, A. M. G., Margollés, A., & Sánchez, B. (2023) · mSystems · doi:10.1128/msystems.00079-23 · Cited by 8
“About 20 mL of reaction mixture for conventional qualitative PCR consisted of 1 µL of DNA (DNA concentrations are summarized in Table S5), each 0.6 µL of 10 µmol/L forward and reverse primer solutions, deoxynucleotide mixture, the DNA polymerase Master Mix RED May/June 2023 Volume 8 Issue 3 10.1128/msystems.00079-23 5…”
BackgroundInfluentialBruggeling, C. E., Groen, M. T., Garza, D. R., Overlaer, F. V. H. T., Krekels, J. P. M., Sulaiman, B.-C., Karel, D., Rulof, A., Schaaphok, A. R., Hornikx, D. L. A. H., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad092 · Cited by 9
“The high prevalence of ClbB in control patients, but also other populations like FAP, 9 suggests ClbB may be relevant for dysplasia development in multiple populations and warrants further research.”
BackgroundSelf-citationGao, X., Zhao, J., Chen, W., & Zhai, Q. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106867 · Cited by 8
A mutational signature that can be made by a bacterium arises in human colon cancer
Yang, Y., & Jobin, C. (2020) · Nature · doi:10.1038/d41586-020-00818-7 · Cited by 7
Yang, Y., Zeng, B., Guo, J., Li, Y., Yang, Y., & Yuan, Q. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02216 · Cited by 7
Hussein, M. T., Al-Qaysi, S. A. S., Rathi, M. H., Hussein, Q. I., & Moussa, T. A. A. (2020) · Baghdad Science Journal · doi:10.21123/bsj.2020.17.3(suppl.).1113 · Cited by 7
“This suggests the relatedness of colibactin-producing genes to increase and induce tumor in the host cell (25).”
BackgroundChen, Q., Deng, Y., Chen, J., Zhao, J., Bi, X., Zhou, J., Li, Z., Huang, Z., Zhang, Y., Chen, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.793653 · Cited by 8
Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
Zhang, X., Li, J., Lan, X., & Li, J. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.280 · Cited by 8
Intratumoral microbiota as cancer therapeutic target
Guo, C., An, Q., Zhang, L., Wei, X., Xu, J., Yu, J., Wu, G., & Ma, J. (2024) · Aging Medicine · doi:10.1002/agm2.12359 · Cited by 7
L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli
Devaux, A., Villéger, R., Roche, G., Diémé, B., Rodrigues, M., Juban, C., Lagrée, M., Venisse, N., Jousse, C., Barnich, N., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2515480 · Cited by 9
Colorectal cancer-associated Streptococcus gallolyticus : a hidden diversity expose
Périchon, B., Cokelaer, T., Teh, W. K., du Merle, L., Ma, L., Touchon, M., Doloy, A., Poyart, C., Givskov, M., Trieu‐Cuot, P., et al. (2025) · Journal of Bacteriology · doi:10.1128/jb.00230-25 · Cited by 6
“The oncogenic role of E. coli pks + and enterotoxinogenic B. fragilis in colorectal cancer has been well documented (14).”
Anna Karenina Principle, Immune‐Oncology‐Microbiome Trio and Cancer Microbiome Therapy
Ma, Z. S. (2025) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.70004 · Cited by 11
Contextualizing TH17 cells in cancer
Pang, D., Bertocchi, A., Powrie, F. M., & Pohin, M. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01250-6 · Cited by 9
Popov, J., Caputi, V., Nandeesha, N., Rodriguez, D. A., & Pai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111365 · Cited by 98
Deciphering the Tumor–Immune–Microbe Interactions in HPV-Negative Head and Neck Cancer
Hu, M., Coleman, S. S., Fadlullah, M. Z. H., Spakowicz, D. J., Chung, C. H., & Tan, A. C. (2023) · Genes · doi:10.3390/genes14081599 · Cited by 7
Zhou, X., Sun, H. J., Ren, J., Yan, G., Yang, L., Zhang, H., Lu, H., Li, X., Makino, T., Yin, F., et al. (2024) · MedComm · doi:10.1002/mco2.556 · Cited by 7
“23 26 In addition to exert the influence on cell microorganisms, gut microbiota and its metabolites also induced intestinal diseases, for example, gut microbiota-derived metabolic pathway, particularly microbial bile acid (BA) metabolism, played important roles in CRC progression.”
BackgroundFu, X., Xu, Y., Han, X., Lin, X., Wang, J., Li, G., Fu, X., & Zhang, M. (2025) · Biological Procedures Online · doi:10.1186/s12575-025-00266-5 · Cited by 7
Microbiome and Gastroesophageal Disease: Pathogenesis and Implications for Therapy
D’Souza, S. M., Cundra, L. B., Yoo, B. S., Parekh Parth, J., & Johnson, D. A. (2020) · Annals of Clinical Gastroenterology and Hepatology · doi:10.29328/journal.acgh.1001018 · Cited by 8
“Biofilms have been observed in association with GI disease, most notably in oral and colonic pathology [24,25].”
Lopez, L. R., Barlogio, C. J., Broberg, C. A., Wang, J., & Arthur, J. C. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.670005 · Cited by 7
Mudd, A. M., Gu, T., Munagala, R., Jeyabalan, J., Fraig, M., Egilmez, N. K., & Gupta, R. C. (2021) · Oncoscience · doi:10.18632/oncoscience.548 · Cited by 6
“Furthermore, a recent study looking at the bacterial composition in individuals with FAP compared to normal controls found that the colonic mucosa of individuals with FAP were highly enriched with genes for the toxin, BFT, that is secreted by the ETBF bacteria [38].”
BackgroundMicrobiome and the Hallmarks of Cancer
Bleich, R. M., & Arthur, J. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_1 · Cited by 8
Advances in Organoid Culture Research
Xie, Z., Wang, L., & Zhang, Y. (2022) · Global Medical Genetics · doi:10.1055/s-0042-1756662 · Cited by 10
Campillo-Gimenez, L., Ríos-Covián, D., Rivera–Nieves, J., Kiyono, H., Chu, H., & Ernst, P. B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.752304 · Cited by 6
“Other bacterial species, such as Fusobacterium nucleatum, have been implicated in CRC without obvious inflammation (Castellarin et al., 2012; Sears and Garrett, 2014; Garrett, 2015; Wang and Jia, 2016; Dejea et al., 2018; Yang and Jobin, 2018).”
BackgroundDi Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10522-5 · Cited by 5
“…strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC and are therefore associated with the inflamed and neoplastic mucosa, where they can promote both the onset and progression of CRC [126, 153, 154].”
Role of Crosstalk Between Gut Microbiota and Immune Cells in Colorectal Cancer: A Narrative Review
Ye, M., Yuan, G., Jin, Y., & Zeng, X. (2025) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000172 · Cited by 5
Nervous system–gut microbiota–immune system axis: future directions for preventing tumor
Wang, J., Cheng, W., & Yang, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535955 · Cited by 11
“…and E. coli (68), Enterococcus hirae and Bi fi dobacterium longum (69), Enterococcus hirae , Faecalibacterium and Lactiplantibacillus plantarum (68), Streptomyces , Pseudoxanthomonas , and Saccharopolyspora (70) are related to antitumor immunity, whereas enterotoxigenic B. fragilis (71), F.…”
Sadegh, R. K., Saleki, K., & Rezaei, N. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114837 · Cited by 6
Morsy, Y., Walberg, Ã., Wawrzyniak, P., Hubeli, B., Truscello, L., Mamie, C., Niechcial, A., Gueguen, E., Manzini, R., Gottier, C., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2530157 · Cited by 4
“2,18,21 Bacterial genes at primary tumor sites in patients with CRC or oral squamous cell cancer have been observed in cancer and immune cells, 4,8 and regions containing bacterial sequences within the tumor tissue have been associated with an increase in the population of myeloid cells.”
The Association of Gut Microbiota With TRPM7 Genotype, Colorectal Polyps, and Magnesium
Sun, S., Zhu, X., Huang, X., Yu, C., Su, T., Murff, H. J., Ness, R. M., Azcárate-Peril, M. A., Shrubsole, M. J., & Dai, Q. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.07.015 · Cited by 5
The silent invaders: Biofilms in neurological, cardiovascular, and metabolic diseases
Kumar, V., & Tyagi, A. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123886 · Cited by 5
Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3
Yu, L. C., Wei, S., Li, Y.-H., Huang, C., Pai, Y.-C., Hung, Y.-M., Lai, L., & Ni, Y. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00732-1 · Cited by 5
Yang, J., Dong, Y., Chen, Y., Liang, H., Rong, S., Liu, Z., & Lang, Q. (2025) · Oncology Letters · doi:10.3892/ol.2025.15273 · Cited by 10
“Consequently, innovative micro‑ organism‑based therapies, including probiotics, prebiotics, synbiotics, fecal microbiota transplantation (FMT), engi‑ neered microbiota, phage therapy and oncolytic virus therapy, are gaining traction in tumor prevention and treatment (72).”
Pai, Y.-C., Huang, C., Lin, L.-Y., Li, Y.-H., & Yu, L. C. (2025) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-25-00045 · Cited by 7
Wang, J., Su, Z., Zhang, X., Wang, S., Chen, X., Xu, X., He, B., & Zheng, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123915 · Cited by 6
Zhai, Z., Li, X., Shang, S., Ma, S., Liang, X., Yin, S., Wu, M., Yu, J., Song, Q., & Chen, D. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02623-z · Cited by 5
“…( B. fragilis ) exerts a similar effect comparable to that of E. coli and Hp , as it resides within the epithelial cells of the intestinal mucosa in patients with familial adenomatous polyposis, and causes substantial DNA damage within these cells, which further aids in the development of CRC [91].”
Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody
Guo, Y., Ouyang, Z., He, W., Qin, Q., Zhang, J., Yu, T., Jiao, M., Hwang, P. M., Zheng, F., Muyldermans, S., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2025.12.009 · Cited by 9
Integrating germline and tumor sequencing to improve hereditary cancer diagnosis and care
de Voer, R. M., & Valle, L. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02046-5 · Cited by 5
“This enrichment was attributed to the presence of patchy bacterial bio fi lms containing these toxin-producing species [59].”
Role of gut microbiota in regulating host cell metabolism in digestive system diseases
Zhan, X., Cao, Z., Wang, S., Xia, H., Wu, H., He, Z., & Fang, X. (2026) · TransMed · doi:10.1016/j.tmed.2026.100019 · Cited by 6
Changes of gut microbiota and short chain fatty acids in patients with Peutz–Jeghers syndrome
Zhou, A., Tang, B., Xie, Y., Li, S., Xu, X., Wu, L., Tu, D., Wang, S., Feng, Y., Feng, X., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03132-0 · Cited by 6
“…adenomatous polyposis (FAP), which is similar to PJS, was found to have enriched Bacteroides fragilis and Bacteroides fragilis toxin (bft) in the colonic mucosa compared to healthy individuals, which increased the risk of faster tumor onset and greater mortality of colorectal cancer (CRC) [27].”
BackgroundDougherty, M. W., Hoffmann, R. M., Hernandez, M. C., Airan, Y., Gharaibeh, R. Z., Herzon, S. B., Yang, Y., & Jobin, C. (2025) · mSphere · doi:10.1128/msphere.00692-24 · Cited by 6
“While a growing body of literature investigates how other bacteria (24, 25) or environmental conditions in the gut (26–31) may influence the genotoxic and carcinogenic capability of colibactin-producing bacteria, host genetic pathways impacting cellular responses to the genotoxin remain less well…”
Zhang, L., Duan, X., Zhao, Y., Zhang, D., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526589 · Cited by 9
“Enterotoxigenic B. fragilis ( ETBF ) and pks + E. coli can produce toxins that cause DNA damage, potentially leading to tumor initiation in the colon (60, 61).”
Microbes Contribute to Chemopreventive Efficacy, Intestinal Tumorigenesis, and the Metabolome
Ferrara, C. R., Bai, J. D. K., McNally, E. M., Putzel, G., Zhou, X. K., Wang, H., Lang, A., Nagle, D. A., Denoya, P. I., Krumsiek, J., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0244 · Cited by 6
Self-citationMonahan, K. J., Swinyard, O., & Latchford, A. R. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0500 · Cited by 5
Colibactin mutational signatures in NTHL1 tumor syndrome and MUTYH associated polyposis patients
Terlouw, D., Boot, A., Ducarmon, Q. R., Nooij, S., Jessurun, M. A., van Leerdam, M. E., Tops, C. M. J., Langers, A. M. J., Morreau, H. M., van Wezel, T., et al. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23208 · Cited by 5
Techniques, procedures, and applications in microbiome analysis
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.01.003 · Cited by 5
Dorobisz, K., Dorobisz, T. A., & Pazdro-Zastawny, K. (2024) · Cancers · doi:10.3390/cancers16193416 · Cited by 5
“Some bacteria act in a very similar way, secreting toxins that damage DNA, which affects the aggressiveness of the tumor, resulting in increased mortality [45].”
BackgroundFecal occult blood affects intestinal microbial community structure in colorectal cancer
Guodong, W., Wu, Y., Wu, X., Hong, S., Chu, J., Zhanbo, Q., & Han, S. (2025) · BMC Microbiology · doi:10.1186/s12866-024-03721-7 · Cited by 8
Self-citationYang, B., Rutkowski, N., Ruta, A., Gray-Gaillard, E. F., Maestas, D. R., Kelly, S. H., Krishnan, K., Wu, X., Wu, S., Chen, A. R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422169122 · Cited by 5
Self-citationToxigenic gut bacteria, diet and colon carcinogenesis
Keenan, J. I., & Frizelle, F. (2019) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2019.1695636 · Cited by 6
“…that the gene coding for the ETBF toxin (bft) is enriched in biofilms structures detected in patients presenting with proximal CRC (Drewes et al. 2017) as well as being detected in nascent biofilms present on the colonic mucosa of patients with familial adenomatous polyposis (Dejea et al. 2018).”
BackgroundInfluentialFusobacterium nucleatum, rectal cancer and radiotherapy
Mann, E. H., & Maughan, T. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.019 · Cited by 5
Wallace, K., Nahhas, G. J., Bookhout, C. E., Lewin, D., Paulos, C. M., Nikolaishvili‐Feinberg, N., Cohen, S. M., Guglietta, S., Bakhtiari, A., Camp, E. R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.659036 · Cited by 6
“CAs could lead to mucosal barrier compromise and increased microbial translocation, while the trend toward higher IL17a responses may reflect an inflammatory reaction to tumor associated microbes (41, 43).”
BackgroundThe Microbiome: the Link to Colorectal Cancer and Research Opportunities
Cass, S. H., Ajami, N. J., & White, M. G. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00960-6 · Cited by 5
Host–microbiota interaction during cancer progression from bulk to single‐cell level
Ma, Y., Zhu, R., & Liu, N. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.263 · Cited by 5
Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review
Xiu-jun, L., Han, Y., Zhang, A., Miao, J., Sun, H., Ge, Y., Wu, F., & Wang, X. (2019) · Open Journal of Proteomics and Genomics · doi:10.17352/ojpg.000008 · Cited by 5
“In addition, HAMLET (human alpha-lactalbumin lethal to tumor cells) can be used as a new oral drug for the prevention and therapy of colon cancer, especially those with colon cancers carrying APC mutations [153,154].”
BackgroundIntegrating the microbiome into the barrier theory of cancer
Ewald, H. A. S., & Ewald, P. W. (2020) · Evolutionary Applications · doi:10.1111/eva.13066 · Cited by 7
“In the gastrointestinal tract, for example, some symbionts contribute to cancer by processes such as inflammation and damage to the intestinal lining whereas others protect against cancer through a variety of mechanisms, such as production of short-chain fatty acids, which can reduce inflammation, suppress cellular pr…”
BackgroundMicrobiota, mucosal immunity, and Colon cancer
Drewes, J. L., Domingue, J. C., & Housseau, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00008-8 · Cited by 5
Self-citationEpigenetic changes induced by Bacteroides fragilis toxin (BFT)Preprint
Allen, J., Hao, S., Sears, C. L., & Timp, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/301374 · Cited by 6
Self-citationGrowth rate alterations of human colorectal cancer cells by 157 gut bacteriaPreprint
Taddese, R., Garza, D. R., Ruiter, L. N., de Jonge, M. I., Belzer, C., Aalvink, S., Nagtegaal, I. D., Dutilh, B. E., & Boleij, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.14.876367 · Cited by 5
Self-citationColorectal Disease and the Gut Microbiome
Rahman, S., Lu, E., Patel, R. K., Tsikitis, V. L., & Martindale, R. G. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.12.004 · Cited by 5
Zhang, J., Wei, Z., & Fan, G. (2025) · Foods · doi:10.3390/foods14173040 · Cited by 5
“This synergy might originate from the distinctive and interconnected functions of ETBF and pks+ E. coli : ETBF promotes mucin degradation, while pks+ E. coli exhibits genotoxic effects [36,61].”
The gut microbiota and colorectal cancer: Molecular insights and translational implications
Chen, J., Du, X., Shao, M., Sun, Y., Shi, X., & He, S. (2025) · Clinical Surgical Oncology · doi:10.1016/j.cson.2025.100107 · Cited by 5
Hou, M., Li, C.-L., Moi, S., Chen, F.-M., Chen, J.-Y., Shih, S., Kan, J., Yang, S., & Chiang, C.-P. (2026) · Communications Medicine · doi:10.1038/s43856-026-01384-1 · Cited by 5
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
Li, F., Qiao, L., Liang, X., Zhang, Y., Liang, N., Xie, J., Deng, G., Hao, Y., Hu, P., Wu, X., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71575 · Cited by 6
Self-citationThe landscape of tissue-resident microbiota across normal, polyp, and colorectal cancer tissues
Xiang, H., Shen, B., Lao, W., Bai, B., Chen, M., Zhou, L., Yu, G., Zhang, W., Chen, H., Wang, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69705-5 · Cited by 6
Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
Yu, Y., Guo, Z., Luo, Z., Dian, Y., Yang, X., Chen, X., Zeng, F., & Deng, G. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00473-w · Cited by 5
Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer
Gao, Y., Zhou, D., Lu, Y., Yang, L., Gong, X.-J., Chen, M., Liang, S., Huang, W., & Zhang, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40890 · Cited by 5
“The tumor microbiota has been documented to influence cancer pathology by activating oncogenic signals [15], inducing DNA damage [16], and forming immunosuppressive TME [17 – 19].”
Contribution of colibactin-producing Escherichia coli to colonic carcinogenesis
Ishikawa, H., Aoki, R., Mutoh, M., Ishiguro, S., Tanaka, T., Miyoshi, N., Miyamoto, S., Hamoya, T., Yoshida, N., Wakabayashi, K., et al. (2025) · eGastroenterology · doi:10.1136/egastro-2024-100177 · Cited by 4
Devasahayam, B. R. F., Uthe, H., Poeschl, Y., & Deising, H. B. (2025) · Environmental Microbiology · doi:10.1111/1462-2920.70145 · Cited by 4
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.